IGF-1 and hair aging were linked in a 2025 study of genetically modified mice. Mice with excess IGF-1 showed earlier coat changes and signs of aging in hair stem cells. The paper also examined human skin samples, but it did not test a scalp product in people.
Primary paper first published March 30, 2025. Source and publication date checked September 17, 2026.
What is the short version of this hair-aging study?
Researchers asked what happens when mice make excess IGF-1, a protein involved in cell signals. They compared these mice with ordinary mice and examined skin and hair stem cells. The work links a specific experimental change with earlier aging features. It does not turn IGF-1 into a simple good-or-bad label for everyday hair care.
- The paper appeared in Aging Cell in 2025.
- The main experiments used genetically modified mice.
- Human skin samples supplied an observational part of the work.
- The study did not test a finished cosmetic formula in people.
- Different experiments used different sample sizes and methods.
What did the researchers actually compare?
The researchers compared mice engineered to make extra human IGF-1 with mice that did not carry that change. They also looked at naturally older mice. This gave the team more than one reference point: mice of the same age, and older mice whose skin already showed age-related changes. Those comparisons answer different questions.
One comparison asks whether the engineered mice differ from their peers. Another asks whether their features resemble those of older animals. Similarity is useful evidence, but it does not make the engineered model identical to ordinary aging. The added IGF-1 was an experimental change, not a typical hair-care habit.
What did the 2025 mouse study find?
The authors reported earlier graying and other coat changes in the engineered mice. Their skin analyses also showed signs of cellular senescence, a state in which cells stop dividing and change their behavior. The team connected these findings with changes in the hair stem-cell population. These are observations about this model, not forecasts for an individual reader.
Some findings came from photographs and tissue staining. Others came from measurements of gene activity, including single-cell RNA sequencing. That method lets researchers examine patterns in different cell groups. It adds detail beyond a photograph, but it still needs careful interpretation. A cell-level signal and a visible outcome are not interchangeable results.
Interested in 2DDR?
Deoxylocks is a physician-formulated cosmetic scalp hydrogel with 5% 2-deoxy-D-ribose. Clear, odorless, once daily.
How strong is each layer of evidence?
The evidence stage depends on the part of the paper being discussed. An experiment in mice, a laboratory assay, and an observation in human tissue are different kinds of work. The table below compares those stages, not how well products perform. No row establishes a finished scalp product's effect in people.
| Evidence layer | Stage | What it can address | Main limit |
|---|---|---|---|
| Engineered mice | Preclinical animal experiment | Changes following excess IGF-1 in this model | Not ordinary human aging |
| Skin and cell analyses | Laboratory measurements | Cell patterns linked with the observed changes | Not a consumer outcome |
| Human skin specimens | Observational tissue comparison | Differences between sampled age groups | No randomized product test |
| Finished scalp products | Not tested in this paper | No conclusion available | No human product result to report |
Does the human-skin part make this a human trial?
No. Examining donated human skin is not the same as assigning people to use a product and following their outcomes. The paper reports differences in IGF-1 staining between younger and older skin samples. That observation can inform a research question, but it cannot show that changing a person's scalp routine changes hair appearance.
The sampling location also matters. The results describe a comparison using perineal skin, not a consumer scalp-use study. Readers should not silently replace “human skin” with “human scalp results.” Precise descriptions of the sample stop a small detail from becoming a much larger claim as a story is repeated.
What do these results not tell you?
These results do not tell you which scalp product to choose, what amount to apply, or when your hair might look different. They do not establish that lowering or raising IGF-1 would benefit you. They also do not show that a cosmetic ingredient reproduces the experimental changes described in the paper.
What these results do not tell you: The study is not a home protocol. Its mouse experiments do not support changing food intake, taking supplements, or adjusting personal care to target IGF-1. There is no human appearance timeline or finished-product result to copy from this work.
The authors explored several ways to probe their findings. Those experiments helped them investigate the model; they were not instructions for readers. A useful explainer keeps the question the researchers asked separate from the choices a person makes at the bathroom shelf.
How should you read headlines about hair-aging research?
Start with the subject, the comparison, and the outcome. Ask whether the work studied mice, isolated cells, human tissue, or people using a finished product. Then check what changed and how it was measured. This short sequence helps you avoid reading every paper with “hair” in its title as evidence for the same thing.
Keep the online publication date distinct from the issue date. This paper appeared online on March 30, 2025, before its July issue. The first date is the relevant one for judging how recent the work is. A later summary does not make an older experiment new.
For product context, the Deoxylocks ingredient-information page addresses a separate subject. Deoxylocks is a physician-formulated cosmetic scalp hydrogel. It was not tested in the IGF-1 paper, and the paper does not substantiate an appearance claim for it.
What other questions do readers ask about this study?
The most useful follow-up questions concern the study's boundaries. The answers below distinguish a protein from a product ingredient, a tissue observation from a trial, and a laboratory model from everyday aging. Keeping those distinctions intact makes the paper easier to understand without adding conclusions that the researchers did not establish.
Is IGF-1 the same as 2DDR?
No. IGF-1 is a signaling protein. 2DDR is a sugar molecule. Their names refer to different substances; this paper cannot be used as evidence that one behaves like the other.
Did people apply a serum in this study?
No. The human portion involved skin specimens. The paper did not follow people applying a finished scalp serum.
Does more IGF-1 always mean older-looking hair?
The study does not establish that rule for people. Its central experiments involved mice engineered to make excess IGF-1 under specific conditions.
Should I change my diet because of the paper?
No diet recommendation for readers follows from these mouse experiments. The paper does not establish a personal eating plan for hair appearance.
What would make the evidence more relevant to daily use?
A well-designed study of the exact finished product in people, with clear comparison groups and relevant outcomes, would answer a different and more practical question.
Sources
Primary source for this article. Publisher-deposited full text and publication date checked on September 17, 2026.
Deoxylocks 5% 2DDR Scalp Hydrogel
A physician-formulated cosmetic hydrogel for nightly scalp care. Non-hormonal, clear and odorless, applied once daily to the scalp. Backed by a 90-day risk-free return policy.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
